FMC constructs microcrystalline cellulose manufacturing facility in Thailand
The $100m facility, which is expected to start up in late 2014, will initially manufacture colloidal MCC and will be fully-integrated with MCC production, blending, packaging and warehousing.
FMC biopolymer vice president and global business director Mike Smith said the opening of the new MCC plant will help meet the growing demand for innovative food and beverage products in Asia.
"This state-of-the-art site, which increases our global MCC capacity for the food industry by 35%, will allow us to more easily and quickly supply the Asian marketplace with our MCC products and the tailored blends we deliver to meet customer needs," Smith added.
The facility's design will also allow for future volume expansion and the manufacture of different product lines for both the food and pharmaceutical markets, according to the company.
FMC specialty chemicals group president Michael Wilson said: "Our new advanced food laboratory at the FMC Singapore Technical Center, which opened last year, along with the company's new Asia Innovation Center in Shanghai, scheduled to open late this year, plus this new manufacturing facility, are all symbols of our long-term commitment to support our growing customer base in this region."
The company also has MCC manufacturing facilities in Newark, Delaware, US, and Cork, Ireland, where it has recently completed expansion.